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Mice deficient in the nuclear hormone receptor
RORgt have defective development of thymocytes,
lymphoid organs, Th17 cells, and type 3 innate
lymphoid cells. RORgt binds to oxysterols derived
from cholesterol catabolism, but it is not clear
whether these are its natural ligands. Here, we show
that sterol lipids are necessary and sufficient to drive
RORgt-dependent transcription. We combined over-
expression, RNAi, and genetic deletion of metabolic
enzymes to study RORg-dependent transcription.
Our results are consistent with the RORgt ligand(s)
being a cholesterol biosynthetic intermediate (CBI)
downstream of lanosterol and upstream of zymos-
terol. Analysis of lipids bound toRORg identifiedmol-
ecules with molecular weights consistent with CBIs.
Furthermore, CBIs stabilized the RORg ligand-bind-
ing domain and induced coactivator recruitment. Ge-
netic deletion of metabolic enzymes upstream of the
RORgt-ligand(s) affected the development of lymph
nodes and Th17 cells. Our data suggest that CBIs
play a role in lymphocyte development potentially
through regulation of RORgt.
INTRODUCTION
Nuclear hormone receptors (NHRs) are transcription factors that
direct a wide range of developmental, reproductive, and immune
response programs. NHRs share a common modular structure
comprised of a DNA binding domain (DBD) at the N terminus
and a ligand binding domain (LBD) at the C terminus. LBD-ligand
interaction is required for the transactivation of most NHRs, and286 Cell Metabolism 21, 286–297, February 3, 2015 ª2015 Elsevier Inseveral classes of small lipophilic molecules such as hormones,
vitamins, steroids, retinoids, and fatty acids have been identified
as NHR ligands (Huang et al., 2010). The identification of natural
ligands for orphan NHRs is an important step in understanding
how these receptors are regulated by dietary factors or endoge-
nous metabolites.
RORg (NR1F3) is broadly expressed in human and mouse tis-
sues (Hirose et al., 1994; Medvedev et al., 1996; Ortiz et al.,
1995). RORgt is the isoform of RORg that is expressed in
lymphoid tissues and is essential for the development of thymo-
cytes, lymph nodes (Kurebayashi et al., 2000; Sun et al., 2000),
gut-associated lymphoid tissues (GALT) (Eberl and Littman,
2004) and Th17 cells (Ivanov et al., 2006), and a subset of innate
lymphoid cells. Co-crystallization and in-solution binding exper-
iments have identified compounds that can bind to recombinant
ROR molecules. The closely related RORa was co-crystallized
with cholesterol and cholesterol sulfate (Kallen et al., 2004;
Kallen et al., 2002), and inhibition of the cholesterol biosynthetic
pathway with lovastatin downregulated RORa transcriptional
activity (Kallen et al., 2002). RORb formed crystals with either
stearate (Stehlin et al., 2001) or all-trans retinoic acid (ATRA)
(Stehlin-Gaon et al., 2003). Structural studies show that RORs
have relatively large ligand-binding pockets (>700 A˚3), which
could accommodate a variety of different ligands. Indeed,
RORg binds to and forms crystals with oxysterols (Jin et al.,
2010; Wang et al., 2010a, 2010b) and vitamin D derivatives (Slo-
minski et al., 2014), whereas RORb can co-crystalize with fatty
acids and retinoids (Stehlin-Gaon et al., 2003; Stehlin et al.,
2001), which are unrelated to cholesterol. In addition, RORg
has been co-crystallized with various antagonists or inverse ag-
onists with conformations that differ markedly from cholesterol.
The biological relevance of various compounds reported to
bind to the RORs remains unclear.
Cholesterol biosynthesis is a complex process that involves
more than 20 enzymes and biosynthetic steps (Nes, 2011).
These can be classified into a few basic sub-processes: acetatec.
is converted into squalene oxide, which is then cyclized into
lanosterol, and lanosterol is converted into cholesterol (Bloch,
1965). How this pathway regulates the activity of lymphoid cells
is still an open question. We have investigated the role of
sterol lipids in the regulation of RORg transcriptional activity.
Using biochemical and genetic tools, we demonstrated that in
mammalian cells the RORg ligand maps to a step in the choles-
terol biosynthetic pathway that is downstream of lanosterol and
upstream of 4a-methyl-cholesta-8,24-dien-3-one. Binding of
one intermediate metabolite, 4a-carboxy, 4b-methyl-zymosterol
(4ACD8) to the RORg LBD resulted in coactivator peptide
recruitment, which was consistent with the structure of LBD-
4ACD8 co-crystals. Mutations in enzymes of the cholesterol
biosynthesis pathway abrogated the development of RORgt-
dependent lymph node anlagen and the differentiation of Th17
cells. Our results thus suggest that cholesterol biosynthetic inter-
mediates regulate RORgt-dependent immune system develop-
ment and lymphoid functions.
RESULTS
RORg Has Broad Specificity for Sterol Lipids in Insect
Cells
To investigate the nature of RORg ligand, we employed an
insect cell-based RORg reporter system (Huh et al., 2011).
Insects are auxotrophic for polyunsaturated fatty acids, reti-
noids, and sterols and obtain these factors from dietary sour-
ces (Cooke and Sang, 1970). However, some insect cells can
grow in lipid-depleted media (Silberkang et al., 1983), and we
developed a lipid-free chemically defined medium (CDM) for
either the short-term maintenance of Drosophila melanogaster
S2 cells or the continuous culture of Kc167 cells (see Supple-
mental Experimental Procedures). Insect cells grown in media
with fetal calf serum (FCS) displayed strong RORg transcrip-
tional activity (Huh et al., 2011). However, there was no activity
in lipid-free CDM, although activity was restored in choles-
terol-supplemented CDM (Figure 1A). Thus, RORg reporter
activity in insect cells is dependent on sterol lipids. The
NHR transcriptional machinery of insect cells maintained in
lipid-free medium functioned in a conventional coactivator-
dependent manner. The dsRNA knockdown of taiman, the
Drosophila NHR coactivator (Bai et al., 2000), abrogated
RORg reporter activity in Kc167 cells grown in sterol-supple-
mented CDM (Figure 1B). Moreover, culture in lipid-free me-
dium did not affect the specificity of other NHRs, including
dafachronic acid (Daf12) (Motola et al., 2006) and ecdysone
receptors (EcR) (Koelle et al., 1991) (Figures S1A and S1B).
However, in contrast to the Daf12 and EcR receptors, which
are highly selective for their cognate ligands, RORg exhibited
broad specificity for a range of sterols, but not for other lipids
(Figures 1C and 1D).
Mapping the RORg Ligand Biosynthetic Pathway
In mammalian cells, we used three types of RORg reporters
(Figure S1C). RORg reporter activity is ubiquitous in mamma-
lian cells that are maintained in CDM (Figure S2A), supporting
the hypothesis that the ligand for RORg is a common basal
metabolite. Essential metabolic pathways that are conserved
between mammals and insects (Table S1) can be excludedCell Mas a source of the RORg ligand because only sterols rescued
RORg reporter activity in insect cells grown in minimal CDM.
We transfected mammalian cells with a RORg reporter and
probed multiple metabolic pathways either by the addition of
387 common metabolites to cells or by co-transfection with
78 basal metabolic enzymes found in mammalian cells (Tables
S2 and S3). We found that only enzymes of the cholesterol
biosynthetic pathway modulated RORg reporter activity (Fig-
ures 2A and 2B). RORg activity was lost in mammalian cells
that cannot synthesize sterol lipids such as the squalene syn-
thase (Fdft1)-deficient cell line SXLT (Saher et al., 2009) (Fig-
ures 2A and 2C). Complementation of SXLT cells with Fdft1
cDNA or media with soluble squalene (Figure S2E), the prod-
uct of Fdft1, restored RORg reporter activity (Figures 2D and
2E). We examined the enzymes downstream of Fdft1 and
found that cholesterol auxotroph U937 cells deficient in
HSD17B7 (Figures S2B and S2C) (Billheimer et al., 1987)
had RORg reporter activity comparable to that of choles-
terol-sufficient cells (Figures 2F and S2D). Reintroduction of
HSD17B7 in U937ROR cells rescued the cholesterol depen-
dency of these cells and reduced RORg reporter activity
by 90% (Figure S2F). Furthermore, RORg reporter activity
in U937 cells was reduced by sterol biosynthetic inhibitors
lovastatin and Ro 48-8071 fumarate, but not by removal of
cholesterol from synthetic media (Figures 2G and S2G). These
observations support the hypothesis that RORg reporter activ-
ity in U937ROR is dependent on endogenous sterol biosyn-
thesis and not on exogenous cholesterol in FCS. Our results
suggest that the endogenous RORg ligand is downstream of
lanosterol and upstream of 4a-methyl-cholesta-8,24-dien-3-
one, the substrate of HSD17B7 (Figure 2A).
These results predicted that the five enzymes and one scaffold
protein that function downstream of squalene synthase and
upstream of HSD17B7 produce RORg ligand. We carried out
overexpression and shRNA knockdown experiments to further
narrow down the enzymes and products that control RORg ac-
tivity. Transcriptional activity was increased only by overexpres-
sion of CYP51 (Figures 2B and 3A and Table S3) or specifically by
addition of FF-MAS, the product of the conversion of lanosterol
by CYP51 (Figure 3B and S2H). RORg reporter activity in
mammalian cells was reduced, but not completely abolished,
by shRNA knockdown of human CYP51A1 or germline deletion
of mouse Cyp51 (Figures 3C and 3D). These results suggest
that the ligand is the product of either CYP51 or a downstream
enzyme. The residual RORg activity observed inCyp51-deficient
fibroblasts could result from the >100-fold increase in the con-
centration of lanosterol in Cyp51/ cells (Keber et al., 2011).
Lanosterol is the endogenous substrate of CYP51 and a RORg
ligand when given at high concentrations in insect cells (Figures
1C and 2A). Further downstream are the enzymes LBR and
DHCR14; both process FF-MAS into T-MAS (Figure 2A). Thus,
results of knockouts and knockdowns are difficult to interpret,
as these enzymes have redundant function, and one single
LBR allele is sufficient to maintain 20%–44% of endogenous
cholesterol biosynthesis (Wassif et al., 2007). The enzymes up-
stream of HSD17B7 are SC4MOL andNSDHL. All three enzymes
are assembled into a cholesterol biosynthetic complex by
the scaffold protein C14ORF1. In yeast and plants, the ortholog
of C14ORF1, ERG28, tethers and contributes to the assemblyetabolism 21, 286–297, February 3, 2015 ª2015 Elsevier Inc. 287
Figure 1. RORg Reporter Activity Induced by Sterols in Insect Cells
(A) Cholesterol is necessary and sufficient to promote RORg reporter activity in insect cells. D.m. Kc167 cells were grown in continuous cultures in CDM with or
without cholesterol and were transiently transfected with RORg-gal4/UAS firefly luciferase reporter. Representative experiment of n = 3.
(B) RORg reporter activity in insect cells grown in CDM is dependent on the coactivator taiman. Kc167 cells were transfected with RORg reporter described in (A)
plus dsRNA. Cells were incubated overnight with 10 mM 7DHC prior to measurement of luciferase activity. RNAi dsGal4 inhibits expression of the RORg-gal4
fusion protein, RNAi EYFP is negative control, and RNAi Tai is specific for the D.m. coactivator taiman. Representative experiment of n = 10.
(C) CBIs induce RORg reporter activity in Kc cells maintained in sterol-free CDM. Kc cells were transiently transfected with RORg-gal4 as described in (A). 25OH
(25-hydroxycholesterol), 7DHC (7-dehydrocholesterol), and SQL (squalene).
(D) Structure-activity relationships (SAR) of sterols that promote RORg reporter activity in insect cells. Shown are 1 non-cyclic and 8 sterol backbones based on
the position of the internal double bond. The color bar on the right depicts the range (nd to 0.04 mM) as EC50 of RORg reporter activity induced by each compound.
We tested 78 sterols, and 46 were bioactive. Compounds (n = 120) used as negative controls included 101 non-sterol compounds, such as PUFAs, fatty acids,
phospholipids, glycerolipids, amino acid derivatives, and retinoids. nd, no activity detected; 4C, 4-cholest-4-en-3-one; 4C22OH, 4-cholest-4-en-3-one-22-ol;
4,7-cholesten, cholest-4,7-dien-3-one; 4AC4MD0, 4a-carboxy, 4b-methyl-cholesta-3-ol; D7-daf, D7-dafachronic acid. Compound nomenclature: common
sterols are labeled by abbreviation and common name, i.e., 7DHC is 7-dehydrocholesterol; for rare compounds an abbreviation followed by standard
nomenclature for sterol lipids (Nes, 2011) is provided, for example 4AC4MD0 (4a-carboxy, 4b-methyl-cholestan-3-ol).The results are a summary of n = 33 ex-
periments. Each compound was tested at least twice in technical triplicates. Error bars are SDs.
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Figure 2. RORg Reporter Activity Maps to the Cholesterol Biosynthetic Pathway
(A) Metabolic map of RORg reporter activity. Top: enzymes in the pathway. Middle: common names of CBIs. The conventional nomenclature for these sterols is
as follows: Lanosterol (14a,4a,4b-trimethyl-cholesta-8,24-dien-3-ol), FF-MAS (4a,4b-dimethyl-cholesta-8,14,24-trien-3-ol), T-MAS (4a,4b-dimethyl-cholesta-
8,24-dien-3-ol), 4ACD8 (4acarboxy, 4b-methyl-cholesta-8,24-dien-3-ol), 4aM-Z-one (4amethyl-cholesta-8,24-dien-3-one), 4aM-Z-ol (4amethyl-cholesta-
8,24-dien-3-ol). The intermediates in the conversion of lanosterol into FF-MAS and the formyl intermediates of 4ACD8 are not shown.
(B) Heatmap of RORg reporter activity after overexpression of cholesterol biosynthetic enzymes in HEK293T cells co-transfected with RORg-gal4/UAS-firefly
luciferase reporter.
(C) RORg reporter activity is blocked in Fdft1/ SXLT cells transfected as described in (B). Empty vector, A304F = inactive RORgmutant, ROR =WTRORg, Trb =
thyroid hormone receptor, Trb_T3 = Trb plus 50 mM Triiodothyronine. Representative experiment of n = 8.
(D) Transfection of hFDFT1 can rescue RORg reporter activity in SXLT cells. Representative experiment of n = 3.
(E) Supplementation of media with squalene (SQL) can partially rescue the full-length RORg reporter activity from an endogenous Il-23r enhancer element in SXLT
cells. Representative experiment of n = 4. Statistical analysis: two-tailed unpaired Student’s t test. **p < 0.005 with a power of 0.87 for 4 aggregated experiments.
(F) tTA-off inducible RORg reporter activity in U937ROR cells grown in cholesterol-supplemented CDM after removal of doxycycline. Representative experiment
of n = 4.
(G) RORg reporter activity in U937ROR cells maintained in media supplemented with exogenous cholesterol is inhibited in a dose-dependent fashion
by cholesterol biosynthetic inhibitors lovastatin and Ro 48-8071 fumarate. Representative experiment of n = 3. Experiments are technical triplicates. Error bars
are SDs.of enzymatic complexes including ERG11/CYP51 and ERG25/
SC4MOL, the key enzymes that were identified in our enzyme
screen to regulate the synthesis of RORg ligand (Mialoundama
et al., 2013; Mo and Bard, 2005; Mo et al., 2002). In yeast,
mutations in scaffold C14ORF1/ERG28 result in accumulationCell Mof intermediates of 3-keto-sterols and 4a-carboxyl sterols, which
are the products of SC4MOL/ERG25 and NSDHL/ERG26,
suggesting a block in the last step of C4-demethylation driven
by HSD17B7/ERG27 (Gachotte et al., 2001). Thus, SC4MOL
and NSDHL can process substrates independently of ERG28.etabolism 21, 286–297, February 3, 2015 ª2015 Elsevier Inc. 289
Figure 3. RORg Reporter Activity Maps to 4a,4b-Dimethylsterols in the Cholesterol Biosynthetic Pathway
(A) Overexpression of Cyp51 results in increased RORg activity in HEK293T cells. HEK293T cells were transfected as described in Figure 2B. Representative
experiment of n = 3.
(B) FF-MAS is a weak agonist for RORg. HEK293T cells were transfected as in (A). Representative experiment of n = 6; two-tailed unpaired Student’s t test;
*p < 0.05 power of 0.74 (6 aggregated experiments).
(C) HumanCYP51a1-specific shRNAs (shCyp) reduce RORg reporter activity in HEK293T cells, whichwas rescued by overexpression of shRNA-resistantCyp51.
Knockdown of mRNA was >80%. Representative experiment of n = 3.
(D) Residual RORg reporter activity is detected in Cyp51/ fibroblasts. Fibroblasts from Cyp51/ embryos were transfected with the same plasmids as
described in (A).
(E) Knockdown of SC4MOL reduced RORg reporter activity in U937ROR cells. U937ROR cells were transfected with plasmid containing shRNA specific for
SC4MOL. Cells were selected post-transfection with puromycin and then cloned. Shown are the results of four clones compared to a scramble clone control.
Representative of n = 3 experiments.
(F) Knockdown of NSDHL reduced RORg reporter activity in U937ROR cells. U937ROR cells were transfected with plasmid containing shRNAs specific for
NSDHL as described in (D). Representative of n = 2 experiments.
(G) Knockdown ofC14ORF1, the human homolog of 0610007P14rik, results in an increase of RORg reporter activity. HEK293T cells were transfected with RORg-
gal4-driven luciferase reporter system plus plasmids containing C14ORF1-specific shRNAs from the Sigma shRNA mission library. The shRNA validation and
average percentage of mRNA knockdown is shown at the bottom. Representative of n = 3 experiments. Experiments are presented as averages of technical
triplicates. Error bars are SDs.However, the scaffold is necessary to accelerate the processing
of intermediates generated by SC4MOL andNSDHL into choles-
terol. Overexpression of SC4MOL, NSDHL, and C14ORF1
had little to no effect on RORg reporter activity (Figure 2B,
Table S3). This suggests that C4-demethylation is limited by
the availability of the biosynthetic precursor T-MAS, the product
of LBR/DHCR14, in mammalian cells. Furthermore, the shRNA290 Cell Metabolism 21, 286–297, February 3, 2015 ª2015 Elsevier Inknockdown of either SC4MOL or NSDHL reduced RORg re-
porter activity (Figures 3E and 3F), which is consistent with their
involvement in the synthesis of endogenous RORg ligand. In
contrast, shRNA knockdown of C14ORF1 resulted in a 2.5- to
5-fold increase in RORg reporter activity (Figure 3G), which in
turn is compatible with the accumulation of SC4MOL and
NSDHL products in C14ORF1/ERG28 mutant yeast.c.
Characterization of Lipids Bound to RORg
Immunoprecipitated from Mammalian Cells
We next characterized, using liquid chromatography coupled to
mass spectrometry (LC-MS), the lipid species co-immunopre-
cipitated with RORg from mammalian cells (Figure S3A). We
observed several peaks, most of which were consistent with ste-
rol structures, likely corresponding to oxidized cholesterol and
methylsterols (Figure S3B). One of the peaks, with ions of mz
459.3746 [M+H]+, corresponding to a compound with the exact
mass of 458.3668 (±0.0091) Da and expected molecular formula
of C30H50O3, caught our attention, as it was partially displaced
by the competitive RORg inhibitor digoxin (Huh et al., 2011) (Fig-
ure S3C) and is compatible with sterol intermediates down-
stream of lanosterol. We could not define the precise structure
of the lipids bound to RORg due to the limited amount of material
present in the sample. Analysis of the immunoprecipitates by
GC-MS showed that only one non-identifiable sterol was differ-
entially present in RORg immunoprecipitates. The exact mass
of MW 458 suggests a hydroxylated lanosterol derivative. These
could be formed by non-enzymatic or enzymatic action in which
lanosterol is converted into non-canonical CBIs through the ac-
tivity of CYP51 or other enzymes in the cholesterol biosynthetic
pathway (Figure S3D). We therefore synthesized several oxides
of lanosterol, specifically 4a-hydroxymethyl,4b,14a-dimethyl-
cholesta-7,24-dien-3-ol and 4a-formyl,4b,14a-dimethyl-cho-
lesta-7,24-dien-3-ol, which are metabolic precursors of the
4a-carboxylated lanosterol (Figure S3D). These compounds
had no activity in the RORg reporter assay in mammalian cells,
possibly due to already high endogenous ligand-mediated activ-
ity, but showed strong activity in insect cells, with EC50 ranging
from 150 nM to 500 nM. Thus, non-canonical lanosterol products
aswell as canonical CBIsmay potentially serve as RORg ligands.
Furthermore, lipids isolated from endogenous RORg precipi-
tated from 3.5 3 1010 AKR1 thymoma cells show a main ion
of mz 437.3855 Da, which is suggestive of a Na+ adduct of
a 24,25-dihydro lanosterol metabolite. While these results are
not proof, they support our data of a CBI as an endogenous
physiological RORg ligand.
Biochemical and Structural Properties of RORg LBD
Bound to CBIs
Although non-canonical products of lanosterol are plausible
ligands for RORg, the marked increase in activity observed
upon overexpression of CYP51A1 led us to focus our biochem-
ical studies on canonical cholesterol pathway intermediates
downstream of lanosterol. We found that RORg reporter activity
in insect cells correlated well with binding of such compounds
to the recombinant RORg LBD. These bound ligands included
CBIs that are abundant in mammalian cells (Keber et al.,
2011) (Figure 4A). We investigated whether these compounds
have biochemical properties similar to those of other RORg
agonists reported in the literature. We focused on 4a-carboxy,
4b-methyl-zymosterol (4ACD8) (Figure 4B), a CBI product of
SC4MOL. 4ACD8 showed specific agonist activity for RORg
(Figures S4A and S4B), and like 25-hydroxycholesterol, 4ACD8
promoted coactivator peptide recruitment, increased the ther-
mal stability of the RORg LBD (Figures 4C and 4D), and can
compete with inhibitor to restore RORg reporter activity in
mammalian cells (Figure S4C).Cell MReported RORa and RORg-ligand complex structures were
prepared with cholesterol-like compounds (Jin et al., 2010;
Kallen et al., 2002, 2004). We similarly generated crystals of
RORa (Figures S4D–S4H) and RORg in complex with 4ACD8.
In the RORg:4ACD8 crystal structure, Helix 12 was in an active
conformation, tightly packed to the LBD surface, fostering direct
interactions with the coactivator peptide (Huang et al., 2010)
(Figures 4E and 4F). The crystal structure showed a well-ordered
arrangement of the sterol backbone of 4ACD8 in the RORg
ligand-binding pocket with the carboxy group of 4ACD8 contact-
ing amino acid residues homologous in RORa (Q289,Y290) and
RORg (Q286, L287) (Figure 4G). These residues are essential
for the interaction of RORs with their ligands. In RORa, residues
Q289 and Y290 interact with either the 3b-hydroxyl or the sulfate
group of either cholesterol or cholesterol sulfate (Kallen et al.,
2002, 2004). In RORb, residues Q228 and Y229 interact with
the carboxy group of stearate and ATRA (Stehlin-Gaon et al.,
2003; Stehlin et al., 2001), and residues Q286 and L287 in
RORg interact with the 3b-hydroxyl group of oxysterols and
the carboxy group of 4ACD8. These interactions are important
for the binding affinity to RORg because CBIs that have a
4a-methyl group instead of 4a-carboxy group, such as T-MAS,
bind very weakly, if at all, to RORg (Figure 4A). Taken together,
these results suggest that universal and abundant CBIs are
bona-fide RORg agonists with properties similar to those of other
known RORg agonists.
RORgt-Dependent Developmental Programs Are
Regulated by Cholesterol Biosynthetic Enzymes
We hypothesized that if CBIs are physiological modulators of
RORg/gt activity, genetic mutations in enzymes of this pathway
would mimic RORgt deficiency phenotypes. We therefore exam-
ined the development of lymphoid tissues in embryos deficient
for Cyp51. We found that at embryonic day 14.5 (E14.5) the
lymph node anlagen of Cyp51/ embryos (Keber et al., 2011)
were smaller than those of wild-type littermates (Figures 5A–
5C), and development of lymph node structures was stunted
or absent. Themost striking phenotype was a complete absence
of brachial lymph node anlagen in 75% of Cyp51/ embryos
(Figure 5B). While the total number of hematopoietic cells in
lymph node anlagen of Cyp51/ embryos was comparable to
that of wild-type controls, these cells were located outside
the aggregates containing CD4+ and IL7RA+ lymphoid tissue
inducer (LTi) cells. The numbers of IL7RA+ and CD4+ LTi cells
were reduced by approximately 50% in cervical and axillary
lymph node anlagen (Figure 5D). Thus, the developmental pro-
cesses regulated by RORgt were severely affected in Cyp51-
deficient embryos.
We next investigated whether SC4MOL, the enzyme down-
stream of CYP51 that modifies the C4-methyl groups of CBIs,
modulates RORgt-dependent processes. We bred Sc4molf/f
mice (Skarnes et al., 2011) to CD4-cre and RORgt-cre transgenic
animals. The CD4-cre transgene limits the deletion of the tar-
geted alleles to TCRab T cells (Lee et al., 2001), and the
RORgt-cre transgene induces the deletion of Sc4mol in all cells
expressing RORgt, including T cells and LTi cells (Eberl and Litt-
man, 2004). The excision efficiency of the Sc4mol f/f alleles in the
CD4+ T cells of RORgt-cre and CD4-cre animals was above
90%, (Figure S5A) and Sc4mol/ cells failed to expand inetabolism 21, 286–297, February 3, 2015 ª2015 Elsevier Inc. 291
Figure 4. Sterol Lipids Are RORg Ligands
(A) CBIs abundant in mammalian cells bind RORg with high affinity. Binding affinity for recombinant RORg protein was defined by the ability of the compound to
compete with fluoresceinated 25-hydroxycholesterol or by alphascreen technology (lanosterol). Concentrations of different CBIs in total embryonic tissue
measured by mass spectrometry are derived from Keber et al. (2011), and thymic concentration of SC4MOL products 4ACD8 and 4a-hydroxymethyl-cholest-7-
en-3b-ol (4AOHD7) are defined in the Supplemental Experimental Procedures. The concentrations of 25-hydroxycholesterol are estimates from normal mouse
serum and lung tissue (Bauman et al., 2009). ND = not detected; NT = not tested.
(B) Drawing of 4ACD8.
(C) Sterols promote the recruitment of fluoresceinated NCOA2 coactivator peptide to RORg. NCOA2 peptide recruitment was compared between holo and apo
RORg receptor produced in bacteria using fluorescence polarization assay.
(legend continued on next page)
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sterol-free media. Furthermore, Sc4mol/ cells had a 30%–
50% reduction in the in vitro polarization of IL-17+ CD4+ T cells
when compared to wild-type controls, while the differentiation
of Th1 and Treg cells was unaffected (Figures 5E, S5C, and
S5D, data not shown). The Th17 polarization defect of
Sc4mol/ T cells was not due to reduced proliferation or cell
death, as both Sc4mol+/+ and Sc4mol/ cultures had similar
numbers of live cells (data not shown). The Th17 polarization
defect was also not due to the lack of end products of the choles-
terol biosynthetic pathway, as the Th17 polarization defect of
Sc4mol/ T cells could not be alleviated by cholesterol supple-
mentation (Figure S5B) but was rescued by addition of CBIs, like
4ACD8 to media (Figures 5F and S5E). In vivo CD4-cre and
RORgt-cre animals had normal lymphoid populations in their
lymph nodes, thymi, and gut-associated lymphoid tissues. This
suggested that Sc4mol/ cells could obtain CBIs and choles-
terol for cell growth via the endocytosis of exogenous LDL
(Goldstein and Brown, 1990). Alternatively, 4,4-dimethyl-sterols
like FF-MAS and T-MAS, which are upstream of SC4MOL and
are weak RORg ligands at physiological concentrations, may
replace the endogenous RORg ligands in the absence of
SC4MOL, as there is a 500-fold increase in their concentration
in humans with hypomorphic mutations of SC4MOL (He et al.,
2011). A good example of this effect is lanosterol, which at
physiological concentrations (1 mM) has little to no activity in
insect cells, while at higher concentrations it has significant
RORg reporter activity (Figure 1C). Thus, an increase in the
intracellular concentrations of 4,4-dimethylsterols could partially
compensate for the loss of physiological RORg ligand in
Sc4mol/ cells.
DISCUSSION
In this study, we combined biochemical and genetic approaches
to investigate the nature of RORg ligands. RORg is required for
the differentiation of LinCD45+IL7ra+ LTi cells that drive
lymphoid tissue development in the fetus (Kurebayashi et al.,
2000; Sun et al., 2000) and adult LTi-like cells that drive the
development of lymphoid structures in the gut of adult animals
(Eberl and Littman, 2004). We propose that RORg ligands are
endogenous metabolites and not compounds derived from die-
tary or microbial products. The depletion of RORg ligands would
be expected to phenocopy RORg deficiency. Lymph nodes,
Peyer’s patches, cryptopatches, and isolated lymphoid follicles,
as well as RORgt-dependent class 3 innate lymphoid cells are
present in germ-free animals (Hamada et al., 2002; Kanamori
et al., 1996), suggesting that microbiota are not a critical source
of RORg ligands. Germ-free mice reared for generations on
chemically defined low molecular weight diets also have normal
thymocyte (Vos et al., 1992) and lymph node (Wostmann et al.,(D) Sterols increase stability of RORg in thermal denaturation assays. The rate o
empty receptor (apo) with ligand-bound receptor (holo forms). For (C) and (D), Apo
en-3b-ol (4ACD7) (green), and 4ACD8 (lilac).
(E) Ribbon drawing showing the structure of RORg bound to the CBI 4ACD8. The
(red). An LXXLL motif-containing coactivator peptide is shown in red, and Helix 1
(F) A 180 rotation of (E). Graphs with measurements are representatives of n = 3 e
are SDs.
(G) The 4a-carboxy group of 4ACD8 forms a salt bridge with RORg LBD residue
Cell M1970) development. Furthermore, RORgt-dependent Th17 cells
can be differentiated in minimal media containing only amino
acids, vitamins, andminerals, supplemented by a source of insu-
lin and transferrin. These observations suggest that an exoge-
nous source of ligand is not required for RORgt function and
that endogenous ligand is sufficient for most of the physiological
functions of RORgt during lymphoid tissue development.
Our data suggest that the physiological ligands for RORg are
methylated CBIs or their metabolites. Until recently, CBIs were
considered biosynthetic intermediates with no biological activ-
ities of their own. However, evidence is growing for roles of
CBIs in functions other than the synthesis of cholesterol. The
products of CYP51 (FF-MAS) and LBR/DHCR14 (T-MAS), the
result of the 14a-demethylation of lanosterol, have been shown
to promote meiosis (Byskov et al., 1995). Another abundant
CBI, desmosterol, modulates LXR activity in atherogenic macro-
phages (Spann et al., 2012). These data support the hypothesis
that CBIs have intrinsic biological activities that are independent
of their role in cholesterol biosynthesis. Our work extends these
findings and suggests that canonical CBIs such as 4ACD8 can
function as endogenous ligands for RORgt. We would also like
to raise the possibility that non-canonical metabolites may
function as ligands for NHRs. The existence of non-canonical
metabolites of lanosterol has been suggested by genetic and
biochemical studies. Lanosterol was shown in vitro to be a
SC4MOL substrate (Rahier et al., 2006), and lanosterol-C4a-car-
boxy accumulated in yeastwith amutation inERG26/NSDHL, the
enzymedownstreamof SC4MOL (Gachotte et al., 1998). Further-
more, LBR/DHCR14-deficient mice accumulated 4-demethy-
lated FF-MAS, suggesting that FF-MAS, the product of CYP51,
is processed by SC4MOL and that SC4MOL can modify multiple
4,4-dimethyl-sterols in the cholesterol biosynthetic pathway
(Wassif et al., 2007). Our own data indicate that non-canonical
metabolites of lanosterol found in thymus can stimulate RORg
activity in insect cells and may serve as ligands for RORgt in
this tissue.
The canonical CBIs exhibit high affinity for RORg (KD < 150 nM)
and are abundant within cells at intracellular concentrations
ranging from 50 to 5,000 nM. Therefore, these CBIs are advanta-
geously placed to occupy themajority of RORg receptors whose
concentration in thymocytes is projected at 3–30 nM. We esti-
mate that more than 80% of all available RORg would be occu-
pied by an endogenous ligand present at 500 nM. As the function
for occupancy is quite steep, further increases in receptor occu-
pancy from 80% to 98%would require the endogenous concen-
tration of ligand to increase from 500 nM to 5,000 nM. These
calculations, and the fact that many sterol lipids are agonists
for RORg, could explain the moderate effect of exogenous li-
gands on RORg activity in our reporter assays with mammalian
cells and insect cells maintained in FCS.f protein denaturation with increasing temperature was measured comparing
receptor (red), holo 25-hydroxycholesterol (blue), holo 4a-carboxy-cholest-7-
RORg LBD is depicted in green with the ligand inside containing oxygen atoms
2 in blue.
xperiments. Cell culture experiments are in technical triplicates, and error bars
Q286 that is homologous to the 4ACD8 contact residue of RORa (Q289).
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Earlier publications have suggested that oxysterols can poten-
tially serve as RORg ligands. Some of the hydroxymethyl, formyl,
or carboxylated CBIs are oxysterols by definition. However, it
had not been clear whether the RORg ligand is a pre- or a
post-cholesterol oxysterol. Post-cholesterol oxysterols like 25-
hydroxycholesterol are products of the catabolism of choles-
terol. While we observed weak, but specific, RORg reporter
activity with CBIs (Figures S2H, SHI, S4A, and S4B), our data
on oxysterols derived from cholesterol catabolism are in agree-
ment with the observations that many function as inverse ago-
nists of RORg activity in mammalian cells (Wang et al., 2010a,
2010b), although we find that they act as agonists in insect cells
(Table S2). The oxysterols 25 and 22-hydroxycholesterol can
compete with inhibitor and restore RORg transcriptional activity
in mammalian cells lines (Figure S4C). Furthermore, 7a or 7b,27-
dihydroxycholesterol were shown to compete with RORg antag-
onist to restore transcriptional activity and direct expression of
IL-17 in T cells, which suggests that under some conditions
oxysterols can act as agonists in mammalian cells (Soroosh
et al., 2014). However, the ability to compete out antagonists
in mammalian cells is a property of several sterols including
some CBIs (Figure S4C), and the recovery was not much higher
than what was observed in cells without antagonists.
An outstanding question is howRORg is regulated. The exper-
iments in the insect system suggest thatmany sterols can induce
an agonist conformation in RORg. This includes many CBIs and
oxysterols, but not cholesterol (Figures 1C and 1D). Moreover,
oxysterols that are inactive or have been identified as ‘‘inverse
agonists’’ in mammalian cells are agonists in insect cells (Table
S2). Since all these ligands have the ability to induce an agonist
conformation in insect cells, their differential activity in mamma-
lian cells may depend upon post-translational modifications or
protein-protein interactions that can accommodate only some
of the ligands bound to RORg. Furthermore, although our results
suggest that the physiological RORg ligand is universal in
mammalian cells, it is not known whether access to such ligand
regulates transcriptional activity. The intracellular location of the
ligand biosynthesis machinery and RORg may contribute to
regulation, and the concentration of ligand may also be affected
by the differentiation program of RORg-expressing cells. For
example, STAT3 was found bound to the promoter region of
the 0610007P14Rik gene, the mouse homolog of C14ORF1
(Ciofani et al., 2012), and may regulate its levels and, hence,
ligand availability. Further research is needed to clarify the roleFigure 5. Deficiencies in the Cholesterol Biosynthetic Pathway Affect
(A) Lti populations are reduced in cervical lymph node anlagen of E14.5 Cyp51
(B) Brachial lymph node anlagen are absent in E14.5 Cyp51/ mouse embryos.
(C) Lti populations are reduced in axillary lymph node anlagen of E14.5 Cyp51/
fixed with formaldehyde. Whole embryo serial sections of WT (n = 3) and Cyp51/
and hematopoietic lineage marker CD45 (blue).
(D) Quantitation of IL7Ra+ and CD4+ cells in lymph node anlagen of Cyp51/ emb
are quantified as bar graphs of the averages of percent cells per embryo.
(E) Impaired Th17 cell differentiation in RORgt-cre Sc4mol-deficient naive CD4+
polarization (top and bottom panels) and 144 hr after polarization (middle pane
Sc4mol/ animals and polarized side by side as technical triplicates. Th17 polariz
Th1 polarization, representative experiment (n = 3).
(F) Addition of 1 mM4ACD8 rescues Th17 cell differentiation in RORgt-cre Sc4mo
Representative of n = 3 experiments with p < 0.005 and power 0.99 for p < 0.01. D
bars are SDs. Statistics: two tailed unpaired Student’s t test with equal variance
Cell Mof any of these possible regulatory mechanisms in RORg tran-
scriptional activity.
Our data are most consistent with a role for CBIs, which are
universal and abundant inmammalian cells, in positive regulation
of RORg activity. However, there may be multiple ligands medi-
ating positive and negative regulation of RORgt functions in
lymphoid cells, and both cholesterol biosynthetic intermediates
and cholesterol catabolic products may contribute to the activity
of this nuclear receptor. Further studies are needed to determine
the roles of the different ligands in functions mediated by RORgt
in adaptive and innate lymphoid cells and by RORg in the non-
lymphoid organs in which it is expressed. A better understanding
of how these metabolites influence cellular physiology will pro-
vide greater insights into lymphocyte development and function
and may facilitate development of novel therapeutics for inflam-
matory diseases.
EXPERIMENTAL PROCEDURES
CDM
Insect CDMwas comprised of 40%Grace’s Medium (Gibco 11595), 10%Mur-
ashige and Skoog basal salt micronutrient solution (Sigma M0529), 1% NEAS
(Gibco 11140), 1 mM sodium pyruvate, 2% Insulin-Transferin-SeleniumA (ITS-
A) (Gibco 51300-044), and 1% Pluronic F-68 (Sigma P5556). Semi-synthetic
CDM had 2% Yeastolate Ultrafiltrate 503 (Gibco 18200). Kc167 cells were
maintained in continuous cultures in CDM/SSM1, and S2 cells were main-
tained for at least 4 days prior to transfection in SSM1 media.
Th17 Cell Polarization
SortedCD4+CD25-CD44-CD62L+cellswere incubatedovernight in IMDMwith
10% FCS and anti-CD3/CD28/IFN-g/IL-4 (mAb cocktail). The following day,
90% of media was replaced with CDM (IMDM, ITS-X [Gibco 51500], 1% Plur-
onic F-68, mAb cocktail, Tgfb, IL-6) plus synthetic cholesterol (Sigma S5442),
sterols, alone conjugated with recombinant ApoE3 or in FFAm (Table 3 US pat-
ent 8198084) as indicated. Cytokine expression levels were analyzed by FACS.
Transient or Stable Transfections
Full-length RORg and RORg-gal4 fusion proteins were used to drive
firefly luciferase reporters PGL4.31[luc2p/GAL4UAS/Hygro] (luc2p) (Promega
C935A) for mammalian cells and luc2p with a minimal D.m.hsp70 promoter
for insect cells. Renilla luciferase was used for normalization. Open Bio-
systems IRAV-FL060105 library was used for overexpression screening.
Tissues and Embryos
Cyp51 deficiency was introduced by time-mated crosses of cyp51a1fl/fl
females to cyp51fl/wt EIIa cre transgenic males as described (Keber et al.,
2011). Embryos were collected, processed, and stained following (van de Pa-
vert et al., 2009). The investigator performing the section analyses and cellLymph Node Development and Th17 Cell Differentiation
/ mouse embryos.
mouse embryos. Embryos were obtained from time-mated pregnancies and
(n = 4) embryos were prepared and stained for IL7Ra chain (green), CD4 (red),
ryos shown in (A) and (C). Left axillary, right cervical lymph node anlagen. Data
T cells. FACS analysis of Th17 cells stained for IL-17A and IFNg 72 hr after
l). Each experiment compares naive CD4 T cells sorted from Sc4mol+/+ and
ation, representative experiment (n = 6). **p < 0.005 and power 0.96 for p < 0.01.
l/ naive CD4+ T cells. Cells were processed and analyzed as described in (E).
ata are quantified as bar graphs with averages (%) of differentiated cells. Error
; power estimates are for aggregate experiments.
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counts was blinded to the genotype of the sections. All experiments using an-
imals were performed following protocols approved by the NYU Institutional
Animal Care and Usage Committee.RORg IPs
Nuclear extract from HEK293T cells transfected with 3xFlag-RORg-LBD or
CTRL vectors were immunoprecipitated (IP) with anti-Flag magnetic beads
(Sigma M8823) and eluted with 3xFLAG peptide (Sigma F4799). IP quality
control (QC) by western blot (WB) and lipid extracted with 2:1 chloroform:me-
thanol. Solvent and water phase were dried with N2 and analyzed by LC-MS
(Agilent 6420 Q-TOF).Crystallization, Data Collection, and Structure Determination of
ROR-LBDs Bound with 4ACD8
3 mg/ml RORa and RORg-LBD were incubated with 10 mM 4ACD8 and 3-fold
M excess of RIP-140498–509 peptide. Crystals were grown in hanging drops at
9C with 200 mM MgCl2, 9%–21% PEG 3350 RORa, and 0.3 M KNa tartrate
RORg. Diffraction data were collected at Argonne National Laboratory APS
beamline SER-CAT 22-ID, and structures were solved by molecular replace-
ment with PHASER. Data collection and refinement statistics are in Table S4.Binding Assays
Competition assays were performed with 100 nM ROR-LBD loaded with 5 nM
fluorescein-labeled 25-hydroxycholesterol (25OH). This complex of ROR-
25OH was then incubated with increasing concentrations of compounds to
verify if they could act as competitors and displace the 25OH in the ROR-
LBD. In peptide recruitment assays, 5 nM fluorescein-NCOA2 peptide was
incubated with apo or compound-saturated RORg-LBD. Fluorescence polar-
ization was measured on FlexStation 3, and IC50 or KD values were calculated
with GraphPad Prism 5. The CD-melting was performed on AVIV circular di-
chroism spectrometer (Model 420) with 10C–80C gradient (2C, 2 min).
Melting temperatures (Tm) were calculated with KaleidaGraph.Statistical Procedures
Unless otherwise stated, data are averages of triplicates, and error bars are
SDs. Comparisons are two-tailed unpaired Student’s t test with equal or un-
equal variance as indicated. Statistical power was calculated using aggregate
data from multiple experiments.
Additional information can be found in the Supplemental Experimental
Procedures.ACCESSION NUMBERS
The Protein Data Bank accession numbers for the structures of RORg and
RORa with 4ACD8 are 4S14 and 4S15, respectively.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and four tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2015.01.004.AUTHOR CONTRIBUTIONS
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